Cancer Drug for Alzheimer's Treatment Camp Lejeune NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Neil Mac Connell King, MD
100 Brewster Blvd
Camp Lejeune, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Eastern Va Med Sch Of The Med Coll Of Hampton Roads, Norfolk Va 23501
Graduation Year: 1993

Data Provided by:
Sean Hsu
(910) 577-4300
215 Station St
Jacksonville, NC
Specialty
Neurosurgery

Data Provided by:
Coastal Neurological Assoc
(910) 353-3624
227 Memorial Dr
Jacksonville, NC

Data Provided by:
Lori Beth Schneider, MD
(704) 896-5591
19615 Liverpool Pkwy Ste A
Cornelius, NC
Specialties
Neurology
Gender
Female
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1990

Data Provided by:
Steven Steuer Glazier, MD
(336) 716-9728
Medical Center Dr
Winston-Salem, NC
Specialties
Neurological Surgery
Gender
Male
Education
Medical School: Georgetown Univ Sch Of Med, Washington Dc 20007
Graduation Year: 1987

Data Provided by:
Dr.Clarence Ballenger
(252) 633-3744
227 Memorial Drive
Jacksonville, NC
Gender
M
Speciality
Neurologist
General Information
Accepting New Patients: Yes
RateMD Rating
2.4, out of 5 based on 6, reviews.

Data Provided by:
Clarence Ballenger
(910) 353-3624
227 Memorial Dr
Jacksonville, NC
Specialty
Neurology, Alzheimer's Specialist

Megdad Mahmoud Zaatreh, MD
Chapel Hill, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Univ Of Jordan, Fac Of Med, Amman, Jordan
Graduation Year: 1994

Data Provided by:
A Michael A Badruddoja, MD
(414) 805-5220
Durham, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Ross Univ, Sch Of Med & Vet Med, Roseau, Dominica
Graduation Year: 1998

Data Provided by:
Margaret Lucille Parrish, MD
Raleigh, NC
Specialties
Neurology, Neuropathology
Gender
Female
Education
Medical School: Bowman Gray Sch Of Med Of Wake Forest Univ, Winston-Salem Nc 27157
Graduation Year: 1974

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com